Skip Navigation

Brain 2009 132(5):1190-1199; doi:10.1093/brain/awp106
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tallantyre, E. C.
Right arrow Articles by Evangelou, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tallantyre, E. C.
Right arrow Articles by Evangelou, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2009). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease

E. C. Tallantyre1, L. Bø2,3,4, O. Al-Rawashdeh1, T. Owens5, C. H. Polman6, J. Lowe7 and N. Evangelou8

1 Department of Clinical Neurology, School of Clinical Sciences, University of Nottingham, UK 2 Department of Neurology, National Competence Centre for Multiple Sclerosis, Haukeland University Hospital, Bergen, Norway 3 Department of Clinical Medicine, University of Bergen, Bergen, Norway 4 Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands 5 School of Economics, University of Nottingham, UK 6 Multiple Sclerosis Centre, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands 7 School of Molecular Medical Sciences, University of Nottingham, UK 8 Department of Neurology, Nottingham University Hospital NHS Trust, Nottingham, UK

Correspondence to: Nikos Evangelou, Department of Neurology, Nottingham University Hospital NHS Trust, Nottingham NG7 2UH, UK E-mail: nikos.evangelou{at}nuh.nhs.uk

The pathological substrate of progressive disability in multiple sclerosis is hypothesized to be axonal loss. Differences in the demographic, pathological and radiological features of patients with primary progressive compared with secondary progressive multiple sclerosis raise the question as to whether they actually represent separate clinical entities. So far, large pathological studies comparing axonal damage between primary progressive and secondary progressive multiple sclerosis have not been reported. In this clinico-pathological study we examined the cervical spinal cord in patients with primary and secondary progressive multiple sclerosis. Human cervical spinal cord was derived at autopsy from 54 patients (17 primary progressive, 30 secondary progressive and 7 controls). Tissue was stained immunohistochemically and examined to determine: (i) the number of surviving corticospinal tract axons; (ii) the extent of grey and white matter demyelination; (iii) the degree of inflammation inside and outside of lesions; and (iv) the relationship between demyelination and axonal loss. Associated clinical data was used to calculate expanded disability status scale for each patient preceding death. Motor disability in the primary progressive and secondary progressive groups was similar preceding death. Secondary progressive multiple sclerosis patients showed considerably more extensive demyelination of both the white and grey matter of the cervical spinal cord. The total number of corticospinal axons was equally low in primary progressive and secondary progressive multiple sclerosis groups versus controls. The reduction of axonal density in demyelinated regions compared to normal appearing white matter was significantly more extensive in primary progressive versus secondary progressive patients (33% reduction versus 16% reduction, P < 0.001). These findings suggest axonal loss is the pathological substrate of progressive disability in both primary progressive and secondary progressive multiple sclerosis with a common plaque-centred mechanism. More extensive axonal loss within areas of demyelination in primary progressive multiple sclerosis could explain high levels of axonal loss observed in these patients despite low levels of demyelination.

Key Words: multiple sclerosis; axonal loss; primary progressive; secondary progressive

Received January 27, 2009. Revised April 3, 2009. Accepted April 3, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.